These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 36052081)

  • 1. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective.
    Papait A; Ragni E; Cargnoni A; Vertua E; Romele P; Masserdotti A; Perucca Orfei C; Signoroni PB; Magatti M; Silini AR; De Girolamo L; Parolini O
    Front Immunol; 2022; 13():960909. PubMed ID: 36052081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CM from intact hAM: an easily obtained product with relevant implications for translation in regenerative medicine.
    Silini AR; Papait A; Cargnoni A; Vertua E; Romele P; Bonassi Signoroni P; Magatti M; De Munari S; Masserdotti A; Pasotti A; Rota Nodari S; Pagani G; Bignardi M; Parolini O
    Stem Cell Res Ther; 2021 Oct; 12(1):540. PubMed ID: 34641958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.
    Ragni E; Papait A; Perucca Orfei C; Silini AR; Colombini A; Viganò M; Libonati F; Parolini O; de Girolamo L
    Stem Cells Transl Med; 2021 Jul; 10(7):1044-1062. PubMed ID: 33656805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles Derived from Primed Mesenchymal Stromal Cells Loaded on Biphasic Calcium Phosphate Biomaterial Exhibit Enhanced Macrophage Polarization.
    Rana N; Suliman S; Al-Sharabi N; Mustafa K
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
    Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
    Front Immunol; 2018; 9():2538. PubMed ID: 30473695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells.
    Magatti M; Masserdotti A; Bonassi Signoroni P; Vertua E; Stefani FR; Silini AR; Parolini O
    Front Immunol; 2020; 11():1156. PubMed ID: 32582218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
    Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
    Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amniotic Membrane-Derived Stromal Cells Release Extracellular Vesicles That Favor Regeneration of Dystrophic Skeletal Muscles.
    Sandonà M; Esposito F; Cargnoni A; Silini A; Romele P; Parolini O; Saccone V
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T
    Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo.
    Cheng A; Choi D; Lora M; Shum-Tim D; Rak J; Colmegna I
    Stem Cell Res Ther; 2020 Dec; 11(1):539. PubMed ID: 33317598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.
    Monguió-Tortajada M; Roura S; Gálvez-Montón C; Pujal JM; Aran G; Sanjurjo L; Franquesa M; Sarrias MR; Bayes-Genis A; Borràs FE
    Theranostics; 2017; 7(2):270-284. PubMed ID: 28042333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality.
    Skovronova R; Scaccia E; Calcat-I-Cervera S; Bussolati B; O'Brien T; Bieback K
    J Transl Med; 2023 Oct; 21(1):723. PubMed ID: 37840135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human amniotic mesenchymal stem cells and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K/AKT signaling pathway.
    Li JY; Ren KK; Zhang WJ; Xiao L; Wu HY; Liu QY; Ding T; Zhang XC; Nie WJ; Ke Y; Deng KY; Liu QW; Xin HB
    Stem Cell Res Ther; 2019 Aug; 10(1):247. PubMed ID: 31399039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles.
    Bremer M; Nardi Bauer F; Tertel T; Dittrich R; Horn PA; Börger V; Giebel B
    Cytotherapy; 2023 Aug; 25(8):847-857. PubMed ID: 37097266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal/stem cell tissue source and in vitro expansion impact extracellular vesicle protein and miRNA compositions as well as angiogenic and immunomodulatory capacities.
    Liu Y; Sun L; Li Y; Holmes C
    J Extracell Vesicles; 2024 Aug; 13(8):e12472. PubMed ID: 39092563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles.
    Gómez-Ferrer M; Villanueva-Badenas E; Sánchez-Sánchez R; Sánchez-López CM; Baquero MC; Sepúlveda P; Dorronsoro A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls.
    Pianta S; Magatti M; Vertua E; Bonassi Signoroni P; Muradore I; Nuzzo AM; Rolfo A; Silini A; Quaglia F; Todros T; Parolini O
    J Cell Mol Med; 2016 Jan; 20(1):157-69. PubMed ID: 26515425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage Polarization.
    Lo Sicco C; Reverberi D; Balbi C; Ulivi V; Principi E; Pascucci L; Becherini P; Bosco MC; Varesio L; Franzin C; Pozzobon M; Cancedda R; Tasso R
    Stem Cells Transl Med; 2017 Mar; 6(3):1018-1028. PubMed ID: 28186708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
    Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
    Front Immunol; 2018; 9():2837. PubMed ID: 30564236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.